Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial

Ítems similars

• P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
  per: Uday R. Popat, et al.
  Publicat: (2023-08-01)
• Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial
  per: Rohtesh S. Mehta, et al.
  Publicat: (2019-12-01)
• Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation
  per: Rima M. Saliba, et al.
  Publicat: (2020-02-01)
• Development and explainable AI-driven characterization of a prognostic model for haploidentical transplantation outcomes
  per: Rohtesh S. Mehta, et al.
  Publicat: (2026-03-01)
• Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
  per: Betül Oran, et al.
  Publicat: (2025-07-01)